Neonatal-Onset Recurrent Guillain–Barré Syndrome-Like Disease: Clues for Inherited CD59 Deficiency

Abstract

Inherited CD59 deficiency is a rare autosomal recessive disorder characterized by chronic hemolysis, recurrent ischemic central nervous system strokes, and early-onset relapsing peripheral demyelinating neuropathy mimicking recurrent Guillain–Barré syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP). We report a 7-year-old girl who presented with neonatal-onset relapsing weakness accompanied by diffuse sensory-motor demyelinating peripheral polyneuropathy. She was diagnosed as having a CIDP-like disease and partially responded to immunomodulatory treatments. Cranial magnetic resonance imaging showed multiphasic brainstem and cerebellar ischemic lesions consistent with vasculopathy and chronic left middle cerebral artery infarction. Whole exome sequencing (WES) analysis revealed a frameshift deletion in CD59 (c.146delA, p.Asp49Valfs*31). Inherited CD59 deficiency should be considered in the differential diagnosis of patients with early-onset severe neurologic symptoms even without an overt hemolysis. We would like to highlight the role of WES in the diagnosis of a condition with a targeted therapy.

Keywords

neonatal onset - recurrent GBS - CD59 deficiency

Funding

This work was supported by the Hacettepe University (TAY-2015–7335).

• References

• 1 Anastasopoulou S, Lindefeldt M, Bartocci M, Wickström R. Acute inflammatory demyelinating polyradiculoneuropathy in a newborn infant. Eur J Paediatr Neurol 2016; 20 (05) 754-757
• 2 Bamford NS, Trojaborg W, Sherbany AA, De Vivo DC. Congenital Guillain-Barré syndrome associated with maternal inflammatory bowel disease is responsive to intravenous immunoglobulin. Eur J Paediatr Neurol 2002; 6 (02) 115-119
• 3 Dilena R, Strazzer S, Esposito S. , et al. Locked-in-like fulminant infantile Guillain-Barré syndrome associated with herpes simplex virus 1 infection. Muscle Nerve 2016; 53 (01) 140-143
• 4 Mossberg N, Nordin M, Movitz C. , et al. The recurrent Guillain-Barré syndrome: a long-term population-based study. Acta Neurol Scand 2012; 126 (03) 154-161
• 5 Nevo Y, Topaloglu H. 88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, December 8-10, 2000. Neuromuscul Disord 2002; 12 (02) 195-200
• 6 Nevo Y, Ben-Zeev B, Tabib A. , et al. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood 2013; 121 (01) 129-135
• 7 Höchsmann B, Schrezenmeier H. Congenital CD59 deficiency. Hematol Oncol Clin North Am 2015; 29 (03) 495-507
• 8 Utine GE, Taskiran E, Kosukcu C. , et al. HERC1 mutations in idiopathic intellectual disability. Eur J Med Genet 2017; 60 (05) 279-283
• 9 Mevorach D. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities. Mol Immunol 2015; 67 (01) 51-55
• 10 Mead RJ, Neal JW, Griffiths MR. , et al. Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis. Lab Invest 2004; 84 (01) 21-28
• 11 Haliloglu G, Maluenda J, Sayinbatur B. , et al. Early-onset chronic axonal neuropathy, strokes, and hemolysis: inherited CD59 deficiency. Neurology 2015; 84 (12) 1220-1224
• 12 Hillmen P, Young NS, Schubert J. , et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006; 355 (12) 1233-1243
• 13 Höchsmann B, Dohna-Schwake C, Kyrieleis HA, Pannicke U, Schrezenmeier H. Targeted therapy with eculizumab for inherited CD59 deficiency. N Engl J Med 2014; 370 (01) 90-92
• 14 Mevorach D, Reiner I, Grau A. , et al. Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation. Ann Neurol 2016; 80 (05) 708-717